Clinical Trial Update: Efficacy/Safety Pilot Study to Investigate Iberogast N's Efficacy in Mild to Moderate Colitis Ulcerosa Patients [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating the efficacy and safety of Iberogast N in mild-to-moderate ulcerative colitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Iberogast N

Snippet

Sponsor: Bayer | Conditions: Colitis, Ulcerative | Phase 2 | Status: TERMINATED